Awakn Life Sciences Corp

XCNQ:AWKN (Canada)  
C$ 0.10 (0%) Dec 24
At Loss
Market Cap:
C$ 3.96M ($ 2.76M)
Enterprise V:
C$ 3.55M ($ 2.48M)
Volume:
-
Avg Vol (2M):
19.26K
Trade In:

Business Description

Description
Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling it to provide breakthrough therapeutics to addiction sufferers in desperate need.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset -2.28
Interest Coverage No Debt
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -81.91
Distress
Grey
Safe
Beneish M-Score -47.23
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -44.9
3-Year EPS without NRI Growth Rate -73.6
3-Year FCF Growth Rate -26

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 27.42
9-Day RSI 36.87
14-Day RSI 41.7
6-1 Month Momentum % 14.29
12-1 Month Momentum % -7.69

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.29
Quick Ratio 0.29
Cash Ratio 0.23
Days Sales Outstanding 362.48

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -16.9
Shareholder Yield % -28.95

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -4172.41
Net Margin % -4134.48
FCF Margin % 5203.45
ROA % -350.69
ROIC % -1852.99
ROC (Joel Greenblatt) % -242000

Financials

XCNQ:AWKN's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Awakn Life Sciences Corp Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 0.058
EPS (TTM) (C$) -0.07
Beta 2.55
Volatility % 126.6
14-Day RSI 41.7
14-Day ATR (C$) 0.006734
20-Day SMA (C$) 0.10225
12-1 Month Momentum % -7.69
52-Week Range (C$) 0.06 - 0.23
Shares Outstanding (Mil) 41.66

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Awakn Life Sciences Corp Filings

Filing Date Document Date Form
No Filing Data

Awakn Life Sciences Corp Stock Events

Financials Calendars
Event Date Price(C$)
No Event Data

Awakn Life Sciences Corp Frequently Asked Questions

What is Awakn Life Sciences Corp(XCNQ:AWKN)'s stock price today?
The current price of XCNQ:AWKN is C$0.10. The 52 week high of XCNQ:AWKN is C$0.23 and 52 week low is C$0.06.
When is next earnings date of Awakn Life Sciences Corp(XCNQ:AWKN)?
The next earnings date of Awakn Life Sciences Corp(XCNQ:AWKN) is .
Does Awakn Life Sciences Corp(XCNQ:AWKN) pay dividends? If so, how much?
Awakn Life Sciences Corp(XCNQ:AWKN) does not pay dividend.

Press Release

Subject Date
No Press Release